The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together

National Medical Journal of China

Volumn 88, Issue 1, 2008, Pages 36-39

  Sun, Ya Nan ^a   Yang, Bao Feng ^b   Liu, Ming ^b   Guo, Yan Ling ^b   Tian, Lin Li ^b   Jiao, Hui ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Laryngeal neoplasms; Lentivirus; Matrix metalloproteinases

Indexed keywords

CYCLINE; GELATINASE A; GELATINASE B; LENTIVIRUS VECTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSDUCTION; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LARYNX CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE, TUMOR; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LENTIVIRUS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 41549098818     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chinese source.
2. Gorogh T, Beier UH, Baumken J, et al. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck,2006,28:31-39.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Liotta LA. Cancer cell invasion and metastasis. Sci Am, 1992, 266:5459, 62-63.
7. Bachmeier BE, Iancu CM, Jochum M, et al. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther,2005, 5:149-163.
8. Heath EI, Burtness BA, Kleinberg L, et al. Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma. Invest New Drugs, 2006, 24: 135-140.
9. Chinese source.
10. Chinese source.
11. Sun Y, Xie M, Liu M, et al. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2. Laryngoscope, 2006, 116:596-601.
12. Chinese source.
13. Mitra A, Chakrabarti J, Banerji A, et al. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol, 2006,25:679-690.